Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Thu, 20.03.2025
freenet AG
Büdelsdorf, 20 March 2025. The Executive Board of freenet AG [ISIN DE000A0Z2ZZ5] has decided, with the approval of the Supervisory Board today, to launch a share buyback programme in the 2025 financial year. Under this share buyback programme, shares in the company are to be repurchased via the stock exchange in the 2025 financial year. The volume [ … ]
Thu, 20.03.2025
SMT Scharf AG
SMT Scharf AG: Managing and Supervisory Board propose the resumption of dividend payments
Hamm, March 20, 2025 – The Managing Board of SMT Scharf AG (German Securities Code (WKN): A3DRAE, ISIN: DE000A3DRAE2) plans to resume dividend payments and, with the approval of the Supervisory Board, decided today to propose a dividend of EUR 0.21 per share [ … ]
Thu, 20.03.2025
MBB SE
Disclosure of inside information acc. to Article 17 MAR
MBB SE adjusts share buyback program 2024/II and buys shares up to a price of €150.00
Berlin, 20 March 2025 - MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, resolved today to make use of the authorization granted by the Annual General Meeting on 26 June 2024 to acquire treasur [ … ]
Thu, 20.03.2025
Circus SE
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
Circus SE resolves capital increase with subscription rights of up to EUR 21.3 million from authorized capital; Preplacement s [ … ]
Thu, 20.03.2025
Broadview Industries AG
EQS-WpÜG: Broadview Industries AG / Tender Offer
Tender Offer / Target company: Westag AG; Bidder: Broadview Industries AG
20.03.2025 / 11:24 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group.
The bidder is solely responsible [ … ]
Thu, 20.03.2025
HBM Healthcare Investments AG
Further validation of the pioneering science and innovation of the US-based biotech company;
Transaction increases NAV per HBM share by CHF 8.70 (+3.6%); expected cash inflow of USD 50 million for HBM Healthcare Investments from the upfront amount.
HBM Healthcare Investments (SIX: HBMN) today announced that Dren Bio, a private portfolio company, a [ … ]
Thu, 20.03.2025
Helvetia Asset Management AG
Ad hoc announcement pursuant to Art. 53 LR
Basel, 20 March 2025
The fund management company Helvetia Asset Management AG has successfully completed the capital increase of Helvetia (CH) Swiss Property Fund in the amount of around CHF 166 million. All 1,625,000 new units were subscribed. The funds will be used to finance the acquisition of seven pro [ … ]
Thu, 20.03.2025
Cembra Money Bank AG
Ad hoc announcement pursuant to Art. 53 LR
Zurich, 20 March 2025 – Cembra published the agenda items and proposals of the Board of Directors for the Annual General Meeting today. The Annual General Meeting 2025 will take place on Thursday, 24 April 2025 at the Zurich Convention Center (Kongresshaus). The invitation can be accessed on the Cembra web [ … ]
Thu, 20.03.2025
Oldenburgische Landesbank AG
The Shareholders of Oldenburgische Landesbank AG (“OLB”) have reached an agreement to sell the entire share capital of OLB to TARGO Deutschland GmbH, a 100% subsidiary of Crédit Mutuel Alliance Fédérale, which is a leading French cooperative bank, the ninth largest bank in Eurozone in terms of total assets. The completion of the acquisition is sub [ … ]
Wed, 19.03.2025
BioVersys AG
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland. March 19, 2025, 7am CET. Ad hoc announcement pursuant to Art. 53 LR
Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination with first-line TB [ … ]
